Financial implications of the Spending Review and what it means for high quality care

Date: 
Time: 
5.30-7.00pm
Venue: 
The King's Fund
Event type: 
Evening seminar

About this event

The Spending Review is due to be announced on 25 November and will set out the funding for health and local government to 2020.

We will look at the implications of the Spending Review and what it means for the NHS and social care, both in terms of the financial settlement but also for any new policy commitments it may contain.

This will be a real opportunity to debate what this means for London and how, as system leaders, the boards of commissioning and provider organisations will need to work together to ensure continued improvement of the health and wellbeing of London’s diverse population.

Speakers

John Appleby

John Appleby has been Chief Economist at The King’s Fund since 1998. He has worked in the National Health Service in Birmingham and London and as senior lecturer at the universities of Birmingham and East Anglia.

John has published widely on a range of health care finance and economic issues in books, academic journals, reports, magazines and newspapers. He contributes regularly to the British Medical Journal on economic issues. John has also acted as an adviser to the UK government and parliament in various capacities.

As well as his post at The King’s Fund, John is a Visiting Professor at the Department of Economics at City University, where he teaches and carries out joint research with colleagues in the City Health Economics Centre.

Richard Murray

Richard Murray joined The King's Fund as Director of Policy in January 2014.

He initially trained as an economist and spent five years in academia before joining the Department of Health as an economic adviser. Following this, he spent a period of four years as a health care specialist at McKinsey & Co.

In 2003 Richard returned to the Department of Health, where he undertook a number of roles including Senior Economic Adviser, Director of Strategy, Director of Financial Planning and Chief Analyst, and finally Director of Finance, Quality, Strategy and Analysis. In 2013 he moved to NHS England as Chief Analyst before leaving to join The King's Fund.